PODD
$PODD
Insulet Corporation
Medical device maker of Omnipod tubeless insulin delivery system for diabetes management.
Healthcare$193.62
+1.29 (+0.67%)
Day Range$191.89 - $195.16
Prev Close$192.33
Analyst Rating
Strong Buy
31 Buy / 2 Hold / 1 Sell
Subscribers
0
Tracking this ticker
Next Report
—
Weekly updates
Latest Report
PODD: Omnipod Growth vs Recall Risk
Insulet ($PODD) is trading near its 52-week low after a steep pullback despite strong adoption of Omnipod 5 and a strong analyst consensus. The story is now a balance between durable growth and short-term execution and quality risks ahead of Q1 results on May 6, 2026.
Apr 6, 2026